Condition: Infertility · Intrauterine Insemination (IUI) · Sponsor: University Hospital, Toulouse
Intrauterine insemination (IUI) is a common therapeutic option to treate infertility. Typically performed 36 hours post-hCG injection to trigger ovulation. However, research suggests delaying IUI to 42 hours post-hCG may improve egg quality and sperm synchronization for fertilization, leading to higher pregnancy rates. A proposed superiority study aims to compare IUI timing at 36 hours versus 42 hours post-hCG injection to evaluate its impact on live birth rates. The primary objective is to assess the effectiveness (live birth rates) of IUI at two different post-hCG timing intervals (42-43 hours vs 36-37 hours).
This description comes directly from the study's public registry record.
Jessika MOREAU, MD · 567771017 · moreau.je@chu-toulouse.fr
Celia BETTIOL, CRA · bettiol.c@chu-toulouse.fr
Always discuss trial participation with your own doctor first.
| CHU Bordeaux | Bordeaux, France | Not Yet Recruiting |
| CHU La Réunion | La Réunion, France | Not Yet Recruiting |
| CHU Poitiers | Poitiers, France | Not Yet Recruiting |
| CHU Toulouse | Toulouse, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06804538